The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118300956 11830095 6 F 201504 20160923 20151214 20160929 EXP CA-ROCHE-1676022 ROCHE 80.51 YR M Y 0.00000 20160929 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118300956 11830095 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 375 MG SOLUTION FOR INJECTION QOW
118300956 11830095 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 375 MG SOLUTION FOR INJECTION QOW
118300956 11830095 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 14 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 15 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 16 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 17 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 18 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0060A,S0060A,S0065E,S0066B,S0002F, 103976 SOLUTION FOR INJECTION
118300956 11830095 19 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown UNK U 0
118300956 11830095 20 C VENTOLIN ALBUTEROL SULFATE 1 Unknown UNK U 0
118300956 11830095 21 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown UNK U 0
118300956 11830095 22 C RHINOCORT BUDESONIDE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118300956 11830095 1 Asthma
118300956 11830095 19 Product used for unknown indication
118300956 11830095 20 Product used for unknown indication
118300956 11830095 21 Product used for unknown indication
118300956 11830095 22 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118300956 11830095 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118300956 11830095 Arthralgia
118300956 11830095 Blood pressure systolic increased
118300956 11830095 Chills
118300956 11830095 Dizziness
118300956 11830095 Dyspnoea exertional
118300956 11830095 Insomnia
118300956 11830095 Lower respiratory tract congestion
118300956 11830095 Nasopharyngitis
118300956 11830095 Pain in extremity
118300956 11830095 Pneumonia
118300956 11830095 Productive cough
118300956 11830095 Respiratory tract infection
118300956 11830095 Tremor
118300956 11830095 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118300956 11830095 1 20150312 0
118300956 11830095 2 20150520 0
118300956 11830095 3 20150923 0
118300956 11830095 4 20151202 0
118300956 11830095 5 20151230 0
118300956 11830095 6 20160113 0
118300956 11830095 7 20160127 0
118300956 11830095 8 20160224 0
118300956 11830095 9 20160309 0
118300956 11830095 10 20160420 0
118300956 11830095 11 20160504 0
118300956 11830095 12 20160504 0
118300956 11830095 13 20160629 0
118300956 11830095 14 20160714 0
118300956 11830095 15 20160810 0
118300956 11830095 16 20160823 0
118300956 11830095 17 20160907 0
118300956 11830095 18 20160923 0